ITGB2 and exocrine pancreatic carcinoma: Batimastat and another peptide-based MMP inhibitor, GI254023X, have been found to be toxic to pancreatic carcinoma cells lines CD18 and MiaPaCa2 at a concentration of 5 μM after 24 h of exposure [58].